CURE RARE DISEASE INC OUR MISSION IS TO ENABLE AND FINANCE THE DEVELOPMENT OF LIFE-SAVING GENETIC MEDICINES FOR ULTRA-RARE PATIENT POPULATIONS PREVIOUSLY DEEMED TOO RARE TO TREAT. TO REALIZE THIS, OUR UNIQUE ECOSYSTEMS FACILITATES COLLABORATION BETWEEN WORLD-RENOWNED RESEARCHERS AND CLINICIANS, POLICY EXPERTS AND OUR GENEROUS DONORS. TOGETHER, WE ARE FUNDAMENTALLY CHANGING THE ULTRA-RARE DISEASE EXPERIENCE AND BURDEN FOR MILLIONS OFPEOPLE AROUND THE WORLD WITH OUR DISCOVERIES AND METHODS - WHILE BRINGING HOPE TO PATIENTS WAITING FOR A CURE.
Annual Revenue
$4,438,510
Known Funders
16
Grants Received
18
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $4,438,510 | $2,003,149 | $5,973,877 |
| 2022 | $2,300,944 | $1,957,670 | $3,277,567 |
| 2021 | $2,797,783 | $3,210,905 | $839,519 |
| 2020 | $2,486,822 | $2,289,134 | $1,470,434 |
| 2019 | $908,188 | $340,271 | $1,000,002 |
Top Funders
CHANTILLY, VA
HUDSON, OH
ALEXANDRIA, VA
CHICAGO, IL
ALEXANDRIA, VA
NORWALK, CT
WALTHAM, MA
INDIANAPOLIS, IN
Beverly Hills, CA
Wilmington, DE
Showing top 10 of 16 funders.
Key Personnel
From 2023 IRS 990 filing
RICHARD HORGAN
FOUNDER & CEO
BRENT WARNER
MEMBER
MARK SMITH
MEMBER
KWESI ACQUAY
MEMBER
STEPHANIE HERZOG
MEMBER
MIKE WILLIAMS
MEMBER
JEREMY STERNBERG
MEMBER
JESSICA CURRAN
MEMBER
KLAUS VEITINGER
MEMBER
GREG KLASSEN
MEMBER
Showing 10 of 12 key personnel.
Frequently Asked Questions
Other Nonprofits in Connecticut
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.